𝔖 Bobbio Scriptorium
✦   LIBER   ✦

162 MEK162 (ARRY-162), a novel MEK 1/2 inhibitor, inhibits tumor growth regardless of KRas/Raf pathway mutations

✍ Scribed by S. Winski; D. Anderson; K. Bouhana; R. Impastato; R. Woessner; J. Zuzack; B. Tunquist; J. Garrus; T. Pheneger; P. Lee


Book ID
119602843
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
56 KB
Volume
8
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.